Society for Immunotherapy in Cancer 2022
- Nov 28, 2022
- 1 min read
Presented poster at the Society for Immunotherapy in Cancer Home - SITC 2022 (sitcancer.org), entitled:
Immunotherapy efficacy and tolerability in advanced hepatocellular carcinoma (HCC) in a diverse and underserved population in the United States – Importance of baseline liver function and screening
Comments